Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Suicidality in a placebo-controlled fluoxetine study of body dysmorphic disorder.
See All Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Suicidality in a placebo-controlled fluoxetine study of body dysmorphic disorder.
Phillips KA, Kelly MM. Suicidality in a placebo-controlled fluoxetine study of body dysmorphic disorder. Int Clin Psychopharmacol. 2009 Jan; 24(1):26-8.
View in:
PubMed
subject areas
Double-Blind Method
Female
Fluoxetine
Humans
Male
Serotonin Uptake Inhibitors
Somatoform Disorders
Suicide
Young Adult
authors with profiles
Megan Kelly PhD